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ABSTRACT The GM2 activator protein (GM2AP) is an accessory protein required for the enzymatic conversion of GM2 to
GM3 by hydrolases in the lysosomal compartments of cells. Here, GM2AP interactions with lipid vesicles are investigated by
sucrose-loaded vesicle sedimentation and gel ﬁltration assays, and the effects of pH and lipid composition on membrane binding
and lipid extraction are characterized. The sedimentation experiments allow for facile quantiﬁcation of the percentage of protein
in solution and on the bilayer surface, with detailed analysis of the protein:lipid complex that remains in solution. Optimum binding
and ligand extraction is found for pH 4.8 where <15% of the protein remains surface associated regardless of the lipid compo-
sition. In addition to extracting GM2, we ﬁnd that GM2AP readily extracts dansyl-headgroup-labeled lipids as well as other phos-
pholipids from vesicles. The ability of GM2AP to extract dansyl-DHPE from vesicles is altered by pH and the speciﬁc ligand GM2.
Although the unique endosomal lipid, bis(monoacylglycero)phosphate, is not required for ligand extraction, it does enhance the
extraction efﬁciency of GM2 when cholesterol is present in the vesicles.INTRODUCTION
Ganglioside catabolism occurs within the acidic lysosomal
compartments of cells (1) and many of the catabolic reac-
tions of gangliosides that contain small oligosaccharide
groups require accessory proteins, collectively termed sphin-
golipid activator proteins (SAPs) (2). In vitro assays demon-
strate that SAPs are required for enzymatic activity and the
results imply a structural role of orienting the oligosaccha-
ride headgroup for enzymatic hydrolysis (3). Specifically,
when hydrolases and ganglioside micelles are mixed, little
to no enzymatic cleavage occurs; however, upon addition
of the specific accessory protein, the rate of cleavage
increases (4). The accessory protein GM2 activator protein
(GM2AP) is specific for the hydrolysis of the ganglioside
GM2 to GM3, and in vivo, the protein is believed to bind
and extract GM2 from the intralysosomal vesicles making
the ganglioside headgroup accessible to the hydrolytic
enzyme, beta-hexosaminidase A (HexA), for cleavage (5).
GM2AP has also been shown to act as a lipid transfer protein
(6,7).
The gene encoding GM2AP contains both a pre- and pro-
sequence that direct the expression of GM2AP into the golgi,
with a final location in the cell lysosome (8). The mature
form of the protein, 18 kD, has been isolated from natural
sources (9,10) and expressed as a glycosylated protein
from both insect and yeast cells (11,12) and as a nonglycosy-
lated form in Escherichia coli (13,14). The crystal structure
of nonglycosylated GM2AP reveals a b-cup topology
formed from eight b-strands that form a hydrophobic pocket
(Fig. 1). Numerous structures of GM2AP have been depos-
ited into the Protein Data Bank and reveal different modes
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GM2 (15) and other phospholipids such as phosphatidylgly-
cerol (PG) (15), phosphatidylcholine, oleic acid/lyso-phos-
phatidylcholine (16), and platelet-activating factor/lauric
acid (17). These various ligand binding modes also correlate
with minor conformational changes in the protein structure,
as revealed most strikingly in GM2AP crystallized without
ligand (Protein Data Bank ID 1GM1), where three different
conformations of the protein are found within an 11-mono-
mer unit cell (15). In particular, the most dramatic effects
are observed in the putative membrane binding loops, specif-
ically around W131, where in one conformer the tryptophan
(TRP) moiety is tucked into the protein, compared with an
aqueous exposed conformation in two other conformers.
(Our amino acid numbering scheme for the E.coli recombi-
nant construct expressed and utilized within this manuscript
designates Ser32 of the proGM2AP sequence as Ser1. Some
of the crystallographic assignments and figures within anno-
tated references are shifted 31 amino acids from our
numbering scheme.) Although the numerous crystal struc-
tures provide molecular level insight into how the protein
conformation can adapt to various lipid ligands, a detailed
molecular mechanism for how GM2AP interacts with vesicle
surfaces, extracts ligands, and transfers lipids between vesi-
cles remains unclear. A fluorescence resonance energy trans-
fer (FRET)-based assay demonstrated the in vitro ability of
GM2AP to extract NBD-GM2 from vesicles and to transfer
this ligand from donor vesicles to acceptor vesicles contain-
ing rhodamine-DOPE (18). In addition, surface plasmon
resonance studies of immobilized vesicles indicate that
with certain lipid compositions, particularly those containing
a unique endosomal lipid, bis(monoacylglycero) phosphate
(BMP), GM2AP, and other SAPs can disturb the bilayer
structure and mobilize the vesicles from the surface plasmon
doi: 10.1016/j.bpj.2009.03.065
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FIGURE 1 (A) Ribbon diagram of GM2AP (PDB ID
1G13), showing a b-cup topology, with the location of
the three TRP residues shown in space filling format.
(B) Cartoon showing a putative binding/extraction scheme
for the interaction of GM2AP with lipid bilayers.resonance (SPR) chip (19,20). However, the binding interac-
tions, such as the partioning or kinetics of interaction of
GM2AP with liposomes, have not been fully and systemati-
cally quantified.
As reviewed by White (21), there are two general cate-
gories of methods for determining the partitioning of
proteins or peptides from lipid vesicles: 1), physical separa-
tion and direct measurement of protein concentrations or 2),
spectroscopic investigations where a given spectral feature
correlates with the protein concentration in a given environ-
ment (21). Although both techniques find wide-range use in
the field, spectroscopic techniques, which often rely on the
intrinsic fluorescence emission from a TRP residue or an
incorporated fluorophore in the protein or peptide, are highly
common. In addition, binding assays have been utilized that
exploit the FRET between the donor fluorophore in the
protein and an acceptor fluorophore label incorporated into
the lipid bilayer. The partitioning coefficient of the glyco-
lipid transfer protein (GLTP) was determined by monitoring
the increase in the acceptor fluorescence from FRET with
intrinsic TRP fluorescence of the protein and dansyl-labeled
DHPE lipids (acceptor) incorporated into the liposomes (22).
GM2AP has three TRP residues in its 162 amino acids.
Given that two of these three sites (W63 and W131) are
located in the putative membrane binding loops, it was ex-
pected that TRP fluorescence would be a useful technique
for monitoring the membrane partitioning of GM2AP.
However, this assay was of little use in characterizing the
membrane partitioning of GM2AP. Ultimately, from phys-
ical separation of the protein in solution from that bound to
the vesicle surface via ultracentrifugation sedimentation
with sucrose-loaded vesicles or via gel filtration (23,24),
we show that <15% of GM2AP remains on the surface of
liposomes in the presence and absence of specific ligand
GM2. From analysis of the protein in solution, it is shown
that GM2AP can extract its specific and nonspecific lipid
ligands in the absence of BMP. The ability of GM2AP to
extract dansyl-DHPE (DDHPE) negates the ability to utilize
this probe to monitor membrane partitioning, as was done in
previous studies of GLTP (22). A model for GM2AP parti-
tioning with lipid bilayers is presented in Fig. 1 B. This
model is similar to that proposed for GLTP; however,
a significant difference is that GM2AP can extract nonspe-Biophysical Journal 97(1) 257–266cific lipids from the vesicles, thus establishing an equilibrium
where the majority of the protein has extracted a ligand form-
ing a protein:lipid complex in solution even in the absence of
GM2. Additionally, these findings demonstrate that under
acidic conditions, BMP is not required for lipid extraction,
although it does enhance extraction efficiency, especially
when liposomes contain cholesterol (CHOL). Because
GM2AP functions in the acidic lysosomal compartment,
the optimum pH for membrane binding and lipid extraction




2-oleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (POPG) and BMPdi18:1 or
BMP in chloroform were purchased from Avanti Polar Lipids (Alabaster,
AL) and used without further purification. N-(5-dimethylaminonaphtha-
lene-1-sulfonyl)-1 and 2-dihexadecanoyl-sn- glycero-3-phosphoethanol-
amine (DDHPE) were obtained from Molecular Probes (Eugene, OR) in
the form of powder. Monosialoganglioside GM2 and CHOLwere purchased
from Sigma-Aldrich (St. Louis, MO) as powders. All other reagents were
obtained from Fisher Scientific (Pittsburg, PA) and used as received.
GM2AP
Recombinant GM2AP was prepared using an E. coli expression system as
described in an earlier report (25) and is a modified procedure originally
published by Wright (26). The structural integrity and purity of final protein
samples were verified by circular dichroism spectra and SDS-PAGE. The
circular dichroism spectra are consistent with the GM2AP generated from
insect expression system as reported (20). The protein concentration was
determined by Bradford assay and by absorption at 280 nm using an extinc-
tion coefficient of 23,000 M1cm1.
Preparation of lipid vesicles
Lipid vesicles were prepared by mixing the desired molar ratios of lipids in
chloroform or other solvent. The lipid mixtures were dried under a stream of
nitrogen to produce a dry film. The film was then subjected to at least six
hours of vacuum desiccation. Unless otherwise stated, the lipids were
hydrated in an appropriate volume of sodium acetate (50 mMNaOAc) buffer
at desired pH and were subjected to a couple of freeze-thaw cycles using
liquid nitrogen. Large unilamellar vesicles of the above lipid samples
were prepared by extrusion, consisting of 55 passes through 100 nm polycar-
bonate filters using an Avanti hand-held miniextruder (Avanti Polar Lipids).
Stock solutions of sucrose-loaded vesicle were prepared as described before
(23,24) but hydrated with 176 mM sucrose, 50 mM NaOAC, pH 4.8. The
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light scattering (Brookhaven Instruments, Holtsville, NY). Final phospho-
lipid concentrations were determined on the basis of total phosphate deter-
mination by Malachite Green Phosphate Assay Kit (BioAssay Systems,
Hayward, CA). Lipid percentages given throughout are in units of mol %.
Spectroscopic measurements
Fluorescence spectra were acquired on a FluoroMax-3 fluorimeter (Horiba
Jobin Yvon, Edison, NJ) with a temperature-controlled cell holder. All
experiments were performed at 20 C by using a HAAKE K20 water bath
circulator (Thermo Electron Corporation, Waltham, MA). Measurements
were made using a 4 mm  4 mm light path quartz cuvette (Starna, Atasca-
dero, CA) with excitation and emission polarizers set to 90 and 0 orienta-
tions, respectively (27). Absorption spectra were collected on a Cary 50
Bio UV–Visible Spectrophotometer (Varian, Palo Alto, CA) using a 1 cm
light path microvolume cuvette. All UV absorption measurements were
performed at room temperature.
Fluorescence measurements
The extraction of DDHPE from lipid vesicles by GM2AP as a function of pH
wasmonitored by fluorescence spectroscopy. For these experiments, the exci-
tation wavelength was set to 280 nm and the emission spectra were recorded
from 300 nm to 550 nm to include the TRP fluorescence emission of GM2AP
and the emission ofDDHPE.TheDDHPE-labeled vesicles (POPC:DDHPE¼
9:1, POPC:POPG:DDHPE ¼ 6:3:1 or POPC:GM2:DDHPE ¼ 8:1:1) were
prepared in 50 mM NaOAc buffer (pH 4.8) at a final concentration of
100 mM. Fluorescence spectra were acquired as a function of titrating
GM2AP into the vesicle solution. Samples were allowed to equilibrate for
8 min before spectra were acquired. The DDHPE emission intensities at
518 nm were used to monitor protein-lipid interactions. Signal intensities
were corrected for dilution before subtracting the intensity in the absence of
GM2AP.
Sedimentation assays for membrane partitioning
and DDHPE extraction
The sedimentation procedure is similar to that reported by Buser (24).
GM2AP protein concentration was determined by fluorescamine labeling
(28). The ability of GM2AP to extract DDHPE was determined by quantifi-
cation of the fluorescence intensity of DDHPE in the supernatant and pellet
fractions of samples containing the same total amount of sucrose-loaded
vesicles with varying concentrations of GM2AP (25). Further details are
given in the Supporting Material. The measured fluorescence intensity of
each sample was corrected for the appropriate dilution factor to give Isup
(signal in the supernatant) and Ipel (signal of the pellet). Given a 200 mL
volume of 100 mM lipid (POPC:DDHPE 2:1), the total concentration of
DDHPE in the sample was known to be 33.3 mM. Therefore, the concentra-
tion of DDHPE in the supernatant Csup (in mM) was calculated by:





The residual lipid that remained in the supernatant from unpelleted vesicles
was determined from control experiments (no protein), and these values
were set as Cctr. Therefore, we define the change in DDHPE concentration
in the supernatant, DDDHPE, as:
DDDHPE ¼ Csup  Cctr: (2)
Model for membrane partitioning
Results from sedimentation assays were analyzed according to the equilibria
shown in Fig. 1 B, where the fraction bound to the vesicle surface was deter-
mined quantitatively from knowing the total protein concentration and the
fraction that remained in the supernatant. From the equilibria shown in themodel, an expression that describes the relationship of the fraction of protein
bound, fb, and the accessible lipid concentration [L] can be determined:
fb ¼ ½Am þ ½Bm½Am þ ½Bm þ ½A þ ½B; (3)
where K1, K2 and K3 are defined as follows:
K1 ¼ ½Am½A½L (4)
K2 ¼ ½Bm½B½L (5)
K3 ¼ ½Bm½Am½L: (6)
Rearranging and substituting gives an expression in terms of the equilibrium
constants and accessible lipid concentration as follows:
fb ¼ K1½L þ K1K3½L
2
1 þ K1½L þ K1K3½L2þðK1K3½L=K2
: (7)
Quantiﬁcation of GM2 extraction
GM2 extraction was quantified with an absorption resorcinol assay (29).
For these experiments, 7.5 nmol GM2AP and 200 nmol vesicles containing
10 mol % GM2 with varying concentrations of POPC, Chol, and/or BMP
were mixed in NaOAc buffer (50 mM, pH 4.8) with a total volume of
100 mL and incubated for 20 min at room temperature. Then the mixture
was loaded onto a self-packed column (1.6 mm  500 mm) with sephacryl
S-200. The elution fractions were collected every two drops. The fraction
volume was determined by weight or micro syringe to be on average
45 mL in our experiments. For fractions not containing vesicles, GM2AP
concentration was determined from the optical density at 280 nm
(OD280) with a 1 cm light path microcell. The GM2 concentration in
each fraction (with or without vesicles) was measured by the resorcinol
assay (29,30). Further details are given in the Supporting Material.
RESULTS
Results from sucrose-loaded sedimentation
assays
GM2AP is known to extract GM2 from intralysosomal vesi-
cles, forming a GM2AP:GM2 complex for further reaction
with HexA (31). Here, the partitioning of GM2AP with lipo-
somes was monitored via sucrose-loaded vesicle sedimenta-
tion assays (24). This methodology is based on physical
separation of protein free in solution from that bound to
the vesicle surface, and it easily allows for direct quantifica-
tion of the protein in both environments. From these exper-
iments, the percentage of protein that remained in solution
for a given lipid composition was measured. Because the
total protein concentration was known, the fraction of protein
bound, fb, can easily be calculated from measurements of
protein remaining in solution after centrifugation. Fig. 2
plots the results from a series of sedimentation experiments
performed at pH 4.8, where GM2AP was added to POPCBiophysical Journal 97(1) 257–266
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(PG or BMP) and functional ligand (GM2). These results
show that the fraction of GM2AP bound to the liposomes
reaches a maximum of 15 mol % for lipid concentrations
>150 mM irrespective of the lipid compositions investigated.
The top panel of Fig. 2 shows results from POPC vesicles.
When protein that was isolated in solution was reequilibrated
with a new set of lipid vesicles for >30 min, the same parti-
tioning was obtained, with only 15% of the total protein
pelletted with the sucrose-loaded vesicles. The bottom panel
of Fig. 2 shows results for sedimentation experiments using
POPC:POPG (7:3), POPC:GM2 (9:1) or POPC:BMP:GM2
(7:2:1) vesicles.
The finding that only 15% of GM2AP remains associated
with the vesicle and that lipid composition does not alter the
amount of GM2AP that sediments with the vesicles is
surprising. SPR studies have shown that when the endoso-
mal lipid, BMP, is incorporated into vesicles, an addition
FIGURE 2 Membrane partitioning isotherms of GM2AP from sedimenta-
tion experiments. All experiments were performed in 50 mM NaOAc buffer,
pH 4.8, with final GM2AP concentration of 10 mM. Figures plot the fraction
of GM2AP bound to the lipid vesicles. Protein was incubated with 0 to
500 mM large unilamellar vesicles for 20 min and followed by ultracentrifu-
gation at 100,000  g for 1 h. The protein concentration in the supernatant
was measured by fluorescamine labeling. The top panel shows results for
POPC vesicles. The bottom panel shows results for POPC:POPG (7:3),
circles; POPC:GM2 (9:1), squares; POPC:BMP:GM2 (7:2:1), down trian-
gles. Lines are fits to the data as described within the text. Error bars repre-
sent standard deviations of three separate measurements.Biophysical Journal 97(1) 257–266of GM2AP caused a lowering of the signal below that in
the absence of protein, which was interpreted as mobilization
of the bilayer away from the chip surface (19). From SPR
experiments, it is generally assumed that BMP is required
for lipid extraction. Based on this assumption and other results
from the GM2AP literature (4,18,19,32), it was anticipated
that the amount of protein that sediments with the vesicles
would follow a trend where the greatest ‘‘binding’’ would
be observed for vesicles containing the functional ligand
GM2, followed by those containing the negatively charged
lipid PG, followed by POPC vesicles, and finally, the least
binding was expected for vesicles containing BMP because
of extraction of lipid expected in the presence of BMP. This
anticipated trend relied on the assumption of a simple two-
state model of protein in solution and protein bound to the
surface, where changing the electrostatic charge of the bilayer
or the addition of GM2, would alter the binding affinity.
However, a two-state model of membrane binding cannot
account for these data. An alternative explanation is that
GM2AP can extract both nonspecific and specific ligands
from vesicle surfaces in the absence of BMP. A model for
how GM2AP interacts with lipid vesicles that includes lipid
extraction is depicted in Fig. 1 B. This model is similar to
that proposed for GLTP (22); however, a significant differ-
ence is the ability of GM2AP to extract lipids other than the
ganglioside GM2, so the four-state equilibrium exists even
when only POPC lipids are used. The solid lines in the data
in Fig. 2 are fits to amodel (Eq. 7) that takes into account three
equilibrium constants between a), apo-protein in solution and
the vesicle surface, defined asK1, b), protein and protein:lipid
complex on the bilayer surface, defined asK3 and c), protein:-
lipid complex in solution in equilibrium with the vesicle
surface, defined as K2. Fits to the data can be obtained for
K2< K3< K1. This model implies that apo-GM2AP (protein
without lipid ligand) and the GM2AP:lipid complex have
different membrane binding affinities, with the complex
having a lower affinity (K2 < K1), which may result from
conformational changes in the protein upon binding of
ligands; thus making the GM2AP:lipid complex less able to
bind to the vesicle surface.
GM2AP extracts Dansyl-DHPE from vesicles
forming a complex in solution
GM2AP has been crystallized with numerous lipid ligands
(15–17) and we have previously shown that GM2AP can
form a 1:1 complex with DDHPE when injected from an
ethanol solution (25). Because the fluorescence intensity of
DDHPE blue shifts to a wavelength comparable to that in
benzene solution, we infer that DDHPE binds into the
GM2AP pocket in the mode consistent with that seen for
POPG (15). Various crystal structures for GM2AP show
two distinct lipid binding pockets, one for phosphoglycerol
lipids and one for the gangioside, GM2, where the
sugar headgroup protrudes into solution. The alternative
GM2AP Can Extract Lipids without BMP 261orientation for phosphoglycerol lipids is consistent with the
in vitro finding that GM2AP protects phosphoglycerol lipids
from the action of phospholipase D (33). It is likely that the
DDHPE molecule is oriented within the hydrophobic pocket
of GM2AP similarly to other phospholipids studied.
From sucrose-loaded sedimentation assays of POPC:
DDHPE (3:1) vesicles, we find that the concentration of
DDHPE in the supernatant increases in a linearly dependent
manner as a function of GM2AP concentration, thus indi-
cating that GM2AP can extract the DDHPE ligand from
the vesicles. In addition, the presence of POPG, GM2 or
CHOL does not alter the amount of DDHPE extracted by
GM2AP. Fig. 3 A plots the change in DDHPE concentration
in the supernatant as a function of GM2AP concentration for
POPC vesicles and POPC vesicles containing POPG, GM2,
or CHOL. Analysis of total protein and DDHPE concentra-
tion in the supernatant fractions shows that 85% of the
GM2AP has formed a 1:1 complex with DDHPE; indicating
that GM2AP has a preference of extraction of DDHPE over
POPC, POPG, or CHOL. Thin layer chromatography reveals
that the concentrations of both POPC and DDPHE increase
as a function of GM2AP concentration (Supporting Mate-
rial), indicating that GM2AP extracts not only DDHPE but
also POPC from the liposomes. Note that BMP was not
included in these vesicles and the data present direct
evidence that BMP is not required for the extraction of
DDHPE or POPC.
Given that DDHPE is not the functional lysosomal ligand
for GM2AP, it can be predicted that GM2AP should extract
GM2 more readily than DDHPE from vesicles. Detailed
studies have been performed for quantifying the affinity of
GM2AP for various glycosphingolipids (4,18,19,32), and
GM2 micelles have been shown to prevent GM2AP from
binding a rhodamine labeled fatty acid, R18, and an assay
based on the displacement of R18 by GM2 has been utilized
to test function of GM2AP constructs (6,7). Fig. 3 A shows
that when both DDHPE and GM2 are incorporated into
POPC vesicles, the amount of DDHPE extracted is lowered
when GM2 in present, indicating that GM2AP extracts GM2
from the liposome in preference toDDHPE. In addition, when
GM2AP is preincubated with GM2 micelles, the extraction
of DDHPE is lowered in a dose-dependent manner (Fig. 3 B).
From these experiments, we can infer that GM2AP has a
higher affinity for GM2 than DDHPE. When GM2AP is pre-
incubated with a concentration of GM2 micelles equal to that
of protein (10 mM, corresponding to a 1:1 GM2:GM2AP
ratio), only 1 mM DDHPE was detected in the supernatant.
For this experiment, 100 mM POPC:DDHPE (2:1) vesicles
were utilized. Assuming an equal distribution of DDHPE in
both lipid leaflets, this gives an accessible DDHPE concentra-
tion of 16.5mM.WhenGM2APwas incubatedwith a concen-
tration of GM2micelles that equals that of accessible DDHPE
(value of 1.6 on x-axis in Fig. 3 B), no DDHPE could be
detected in the supernatant. Clearly, the presence of GM2,
whether added to GM2AP before mixing with vesicles orwhen incorporated into the vesicles, mitigates the extraction
of DDHPE, as expected.
BMP is not required for GM2 extraction
It has been reported that the anionic lipid BMP stimulates
sphingolipid degradation and the ability of GM2AP to mobi-
lize lipids from the bilayer surface (19,34). The results of the
A
B
FIGURE 3 (A) GM2AP extracts DDHPE from liposomes. POPC:DDHPE
(2:1), black squares; POPC:POPG:DDHPE (1:1:1), dark gray circles;
POPC:CHOL:DDHPE (47:20:33), black asterisks; POPC:GM2:DDHPE
(47:20:33), light gray up triangles. (B) Preincubation of GM2AP with
GM2 micelles inhibits the extraction of DDHPE. 10 mM GM2AP was pre-
incubated for 20 min with varying concentrations of GM2 micelles, which
ranged from 0 to 15 mM. The GM2AP-GM2 mixture was then allowed to
incubate with POPC:DDHPE (2:1) vesicles for 20 min, followed by ultra-
centrifugation at room temperature. For both A and B, the change in the
DDHPE concentration in the supernatant was determined from fluorescence
measurements as described in the Materials and Methods section. Data
points represent the average value from three separate experiments with
data points representing the standard deviation in A and error bars showing
the standard deviation in B. All experiments were performed in 50 mM
NaOAc, 100 mM KCl, pH 4.8 with 100 mM final lipid concentration.Biophysical Journal 97(1) 257–266
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DDHPE from vesicles in the absence of BMP. GM2AP can
also extract GM2 from vesicles that do not contain BMP,
but BMP enhances the extraction efficiency. Extraction effi-
ciency is defined as the ratio of amount of GM2 relative to
GM2AP recovered after gel-filtration in the nonvesicle frac-
tions. It is a measure of howmany GM2AP protein molecules
extracted GM2 in the experiment. The gel filtration assay was
chosen over the sucrose-loaded vesicle sedimentation assay
because of interference of the remaining sucrose in solution
with the method of detection of GM2. Each of the fractions
from the gel-filtration column were analyzed for protein
concentration and for GM2 concentration. Fig. 4 A shows
an example of results from analysis of gel filtration fractions.
For these experiments, GM2AP was allowed to incubate
for 20 min with vesicles of varying composition before sepa-
ration. The data are shown for POPC:GM2:CHOL:BMP
(50:10:20:20) vesicles in 50 mM NaOAc, pH 4.8 buffer.
Fig. 4 B plots the extraction efficiency (GM2/GM2AP) deter-
mined from this assay for varying lipid compositions. Both
wild-type GM2AP and the AB variant (C107R) construct
(35,36) were characterized. From these data, we can clearly
see that GM2AP can extract GM2 from POPC:GM2 (9:1)
vesicles without the presence of BMP. Specifically, a ratio
of 43 5 7% is found, indicating that this percentage of
GM2AP in solution has formed a complex with GM2. A ratio
of 100% would indicate that every GM2AP protein contains
one GM2 lipid. The ability of GM2AP to extract GM2 is
lessened to 25 5 5% when CHOL is present (POPC:GM2:
CHOL ¼ 70:10:20). When BMP was introduced (POPC:
GM2:CHOL:BMP ¼ 50:10:20:20), 74 5 12% of GM2AP
formed a complex with GM2. The AB variant construct
(C107R) also possesses GM2 extraction ability as a function
of lipid concentration roughly equal to that of the wild-type
GM2AP. This finding that the AB variant extracts GM2 in
a manner similar to the wild-type protein is consistent with
the published results ofXie et al. (37), usingR18 dequenching
assays, which claims that the mutant C107R does not alter the
membrane binding and extraction function but rather,
prevents interactions with HexA.
Monitoring the formation of GM2AP:DDHPE
complex as a function of solution pH
Fig. 5 shows the effects of pH on the ability of GM2AP to
extract DDHPE from POPC vesicles. Two different analyt-
ical assays were used. The top panel of Fig. 5 shows results
from direct measurement of the concentration of DDHPE
that remained in the supernatant after sucrose-loaded vesicle
sedimentation via centrifugation, where POPC:DDHPE
(2:1) vesicles were utilized. The largest change in DDHPE
concentration was observed for pH 4.8. The bottom panel
of Fig. 5 shows the change in fluorescence signal detected
at 518 nm (the emission maximum of DDHPE in the
GM2AP:DDHPE complex) with excitation at 280 nm, as aBiophysical Journal 97(1) 257–266function of solution pH with POPC:DDHPE (3:1) vesicles.
Here, no sedimentation was utilized, only direct spectro-
scopic measurement of changes in fluorescence intensity.
The change in intensity at 518 nm arises from numerous
factors including a change in the fluorescence quantum yield
of DDHPE upon moving into the more hydrophobic environ-
ment of the protein, from resonance energy transfer from the
A
B
FIGURE 4 Gel filtration assay for GM2 extraction. (A) Elution profile of
the mixture of 7.5 nmol GM2AP with 200 nmol POPC:GM2:CHOL:BMP
(50:10:20:20) vesicles in 50 mM NaOAc pH 4.8 buffer with total volume
of 100 ml. The average fraction size was 45 ml. The gray columns show
the concentration of GM2 (determined from resorcinol assay) in each frac-
tion. The black columns show the GM2AP concentration (determined
from UV–VIS) in each fraction. Fractions that contained vesicles were deter-
mined by light scattering at 550 nm. Typically, fractions for elution volumes
>500 mL contained no vesicles. (B) Efficiency of GM2 extraction as a func-
tion of lipid composition for both GM2AP (white) and the AB variant of
GM2AP (light gray). The extraction efficiency is defined as the percent ratio
of GM2 to GM2AP (100*GM2/GM2AP). Error bars represent the standard
deviations of three separate measurements. Lipid compositions: POPC:GM2
(9:1), POPC:GM2:CHOL (70:10:20), POPC:GM2:CHOL:BMP (50:10:
20:20).
GM2AP Can Extract Lipids without BMP 263GM2AP on the surface of the vesicles and from the
GM2AP:DDHPE complex in solution. The quantum yield
of dansyl fluorescence is known to be dependent on the
polarity of the environment and the effects of FRET can
be seen on the decrease of the TRP fluorescence upon addi-
tion of lipid vesicles, which is not seen when POPC vesicles
are added (data not shown). The largest increase in fluores-
cence signal is also detected at pH 4.8. Interestingly, if the
His-tag is left on the protein, the pH profile for maximum
fluorescence signal is altered. This finding can indicate that
the His-tag alters the pH- dependent membrane binding
profile of GM2AP or simply quenches the fluorescence
signal differently at various pH values. The effect was not
investigated further by sucrose-loaded sedimentation exper-
iments.
The 10-His tag alters lipid extraction properties
of GM2AP
Because the fluorescence assay described above has contri-
butions from both the membrane bound state of GM2AP
and the complex formed upon extraction of DDHPE, the
A
B
FIGURE 5 Effects of pH and His-tag on membrane binding and lipid
extraction of GM2AP. (A) Plot of the change in DDHPE concentration in
the supernatant as a function of solution pH for GM2AP extraction deter-
mined from sucrose-loaded vesicle sedimentation assays. For these experi-
ments, 10 mM GM2AP was allowed to incubate for 20 min with 100 mM
POPC:DDHPE (2:1) vesicles before separation by ultracentrifugation. For
each pH value, the change in DDHPE concentration was referenced to
samples that did not contain protein. (B) Percentage change in the fluores-
cence intensity detected at 518 nm with excitation wavelength of 280 nm
for 10 mM GM2AP (solid) or 10 mM GM2AP10His-tag (open) with 50 mM
POPC:DDHPE (9:1) vesicles as solution pH was varied. Initial fluorescence,
F0, of vesicles was taken before addition of protein. The DF signal was
determined by subtracting F0 from the value obtained (corrected for dilution)
after the protein was added and allowed to incubate for 8 min. For both A and
B, the solution buffers contained 25 mM NaOAc and 25 mM phosphate and
the pH was adjusted by acetic acid. Each experiment was performed in
triplicate and data point sizes are indicative of the error.change in the fluorescence intensity at 518 nm can be used
to monitor the kinetics of DDHPE extraction as a function
of solution variables such as salt and pH. Fig. 6 shows results
from kinetic assays as a function of pH and moderate ionic
strength (100 mM NaCl) for GM2AP and without with
His-tag. Fig. 6, A and C show the results without and with
NaCl; respectively, at pH 4.8 for protein with and without
the His-tag. It is clear that although the His-tag does not
change the equilibrium signal (i.e., the change in fluores-
cence intensity reaches the same value within error for times
longer than 10 minutes), the early kinetics of the function are
clearly different. Additionally, the time course profile of
GM2AP containing the His-tag, open symbols, changes
only slightly when 100 mM NaCl is added, whereas for
GM2AP that has had the tag cleaved, a stronger dependence
on ionic strength for extraction of DDHPE is observed and
the kinetics of interaction are slowed, although after
10 min, the change in total fluorescence signal for experi-
ments with and without salt are nearly the same. Fig. 6 B
shows how the pH profile is altered by the His-tag. For
experiments performed at pH 6.4, no increase in fluorescence
signal is detected for GM2AP that has the His-tag cleaved.
However, a moderate increase in fluorescence intensity is
seen for GM2AP that retains the His-tag, indicating some
‘‘function’’ over the 10-minute period. These findings indi-
cate that care must be taken to ensure that the presence of
the His-tag used during purification does not alter the func-
tion of the protein. Interestingly, the His-tag does not alter





FIGURE 6 Effects of His-tag on membrane binding and lipid extraction
monitored by time course fluorescence intensity at 518 nm from 10 mM
GM2AP (solid) or 10 mM GM2AP10His-tag (open) with 50 mM
POPC:DDHPE (9:1) in different conditions. (A) Results obtained for
50 mM NaOAc, pH 4.8, (B) 50 mM NaOAc, pH 6.4; (C) 50 mM NaOAc,
100 mM NaCl, pH 4.8. Results are discussed in the text. Excitation wave-
length was 280 nm.Biophysical Journal 97(1) 257–266
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GM2AP extracts nonspeciﬁc lipids
with low selectivity compared to GM2
and BMP is not required for lipid extraction
The two reported functions of GM2AP, to present GM2 to
HexA for hydrolytic cleavage and to transfer GM2 to accep-
tors, both start with the same initial step: extraction of GM2
from intralysosomal vesicle surfaces. As such, it is of interest
to characterize the membrane binding interactions and lipid
extraction properties in the absence of either HexA or other
acceptor biomolecules. Our findings show that at equilib-
rium, ~85% of GM2AP remains in solution as a complex
with lipid ligands after it has extracted these from donor vesi-
cles. Other reports have shown that GM2AP can bind varied
ligands in vitro, and in those cases, the ligands were intro-
duced in a concentrated ethanolic solution into a purified
solution of GM2AP in acidic buffer (15). It has also been
shown that GM2AP can extract rhodamine-labeled fatty
acids from vesicles (18). Here, it is shown that GM2AP
extracts various lipid ligands from vesicle surfaces; and for
the case of DDHPE with selectivity lower than GM2; as
shown by the inhibitory effect of GM2 on the extraction of
DDHPE when either introduced into the membrane or prein-
cubated with GM2AP in the form of micelles before exposure
to POPC:DDHPE vesicles. Interestingly, GM2AP can also
extract POPC from vesicles, an unexpected finding; although
consistent with x-ray structures showing phospholipids
bound when introduced from ethanolic solution (15,16,17).
In addition, the data reported here clearly demonstrates the
ability of GM2AP to extract lipids from vesicles without
BMP. Both GM2 and DDHPE were extracted by GM2
when incorporated into POPC vesicles. The presence of
CHOL lowered the ability of GM2AP to extract GM2.
Addition of BMP did significantly enhance the extraction
efficiency when CHOL was present.
Intrinsic ﬂuorescence of GM2AP
and Dansyl-DHPE ﬂuorescence cannot
be used to monitor membrane partitioning
As described in the introduction, two of the three TRP
residues ofGM2AP (W63 andW131) are located in two loops
predicted to interact with the membrane surface. A change in
the environment (polarity, hydrophobicity) upon membrane
binding is expected to influence the fluorescence emission
properties of the TRP residues. For GM2AP, only a 1 nm
blue shift in the TRP fluorescence is seen when incubated
with excess POPC vesicles at acidic pH (Supporting Mate-
rial). This blue shift is not seen when the experiment is per-
formed with excess POPC vesicles at neutral pH (data not
shown), indicating that the shift does arise from interactions
with the membrane. But, this variation is too small to use
for partitioning studies or binding kinetics. Additionally,
from the sedimentation and gel-filtration studies, the originBiophysical Journal 97(1) 257–266of this minor shift is now clear; only a small population
of GM2AP is bound to the membrane surface. Clearly,
GM2AP is more properly classified as a lipid extraction or
lipid transfer protein as opposed to a membrane binding
protein. Because GM2AP can extract DDHPE and other
phospholipids from vesicle surfaces, a common FRET-based
assay with DDHPE cannot be used to provide membrane-
partitioning coefficients. Nevertheless, DDHPE vesicles offer
a unique route to study ‘‘function’’ when defined as both
binding and extraction of lipids, as well as providing an assay
to study the kinetics of ligand extraction and release as
solution pH and lipid composition are varied (25).
The existence ofGM2AP-ligand complexes in solution also
implies that care should be takenwhen analyzing other fluores-
cence-based assays with this protein, specifically those based
upon dequenching assays (6,18). Analysis of the numerous
x-ray structures of GM2AP shows that this protein contains
a rather large binding pocket, capable of binding various and
numerous ligands (16). In hindsight, it is not surprising that
GM2AP can form complexes with DDHPE (25) and rhoda-
mine-labeled fatty acids (6,18). However, not all lipid extrac-
tion/binding proteins are able to form complexes with fluores-
cent lipids. For example, the membrane partitioning of the
GLTP has been determined using DDHPE FRET in the pres-
ence of 20% specific ligand galactosylceramide in POPC
membranes (22). Additionally, the Sacchromyces cerviciae
phosphotidylinositol transfer protein, Sec14p, has been shown
to bind spin-labeled fatty acids and phospholipids in addition
to its specific substrates, but appears unable to bind fluores-
cently labeled lipids (38).
The His-tag must be removed for proper
biophysical characterization measurements
It has been documented that the interactions between histi-
dine residues and aromatic residues can change fluorescence
emission profiles as well as protein structure (39–42). For
purification convenience, the N-terminus of GM2AP is fused
with a 10 histidine tag and a Factor Xa cleavage site:
MGHHH HHHHH HHSSG HIEGR-. For GM2AP, the
coexpressed His-tag does not affect protein conformation,
as determined from circular dichroism spectroscopy, or
protein stability, determined from a urea induced unfolding
experiment (Supporting Material). However, its presence
does alter the TRP fluorescence emission spectra under
acidic conditions (data not shown). Most significant are the
effects the His-tag has on the pH profile of DDHPE binding
and extraction kinetics of GM2AP. Thus, the His-tag on
GM2AP must be removed for proper biophysical character-
ization measurements. These results indicate that, in general,
care must be taken when considering the effects that His-tags
have upon protein structure and function. Given that
GM2AP has numerous aspartic acid (ASP) and glutamic
acid (GLU) residues lining the rim of the hydrophobic lipid
binding pocket, it is possible that the His-tag, when
GM2AP Can Extract Lipids without BMP 265protonated for pH < 6.4, interacts through H-bonding with
these residues that surround the binding pocket, thus changing
the electrostatic interactions with the bilayers and interactions
with lipid ligands. Without the His-tag, optimum function is
determined for pH 4.8, which is near the expected pKa values
of ASP and GLU residues in proteins. Binding to bilayers
upon a pH trigger can be understood by considering that under
acidic conditions, the ASP and GLU residues can become
protonated, lessening the charge and the Born repulsion
energy that can promote a more energetically favorable inter-
action with the bilayer surface. It is interesting that the
GM2AP ‘‘function’’ is titratable near the pKa of histidine resi-
dues when the His-tag is present, thus supporting our specu-
lation that the His-tag is interacting with the numerous acidic
residues in GM2AP, whose partial neutralization is likely
important for membrane binding and ligand extraction.
SUPPORTING MATERIAL
Additional experimental details including five figures are available at http://
www.biophysj.org/biophysj/supplemental/S0006-3495(09)00895-9.
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